SynthesisFrontiers in endocrinology2026
Incidence and risk factors of post-transplant diabetes mellitus after kidney transplantation: a systematic review and meta-analysis.
Synthesis in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: In order to investigate the incidence rate of post-transplant diabetes mellitus (PTDM) patients and identify the risk factors, we conducted a systematic review of studies published after 2014. Data sources: PubMed, EMBASE, Cochrane Library, as well as Web of Science were comprehensively retrieved until June 24, 2024. Selection of studies: Extracted data via EndNote reference management software and evaluated the risk of bias through the Newcastle-Ottawa Scale (NOS). Data extraction: Statistical analyses were enabled by STATA 15. Heterogeneity was evaluated through the Q test 、the I² statistic sensitivity and subgroup analyses. Data summary: 26 studies from 15 countries involving 8, 727 participants were encompassed. The overall incidence of PTDM was 20%. Meta-analysis revealed that advanced age (>50), hepatitis C virus (HCV) infection, polycystic kidney disease, high body mass index (BMI), high fasting plasma glucose (FPG), hypertriglyceridemia, as well as hypercholesterolemia were significantly related to elevated risk of PTDM (P < 0.05). Meta-analysis of case-control studies further confirmed that advanced age (OR = 1.07, 95% CI: 1.04-1.09), high BMI (OR = 1.23, 95% CI: 1.08-1.39), and hypertriglyceridemia (OR = 1.01, 95% CI: 1.00-1.02) were significant risk factors. Cohort studies additionally identified advanced age, high BMI, high FPG, family history of diabetes, hypertriglyceridemia, and HCV infection as significant risk factors. Conclusions: The incidence of PTDM after kidney transplantation is approximately 20%. Advanced age, high BMI, family history of diabetes, high FPG, hypertriglyceridemia, and HCV infection are significant risk factors. Among these, BMI, glucose, lipid abnormalities, and HCV infection are modifiable. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42024585070.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.